Literature DB >> 26855200

Rechargeable anticandidal denture material with sustained release in saliva.

A Malakhov1,2, J Wen3, B-X Zhang1,2, H Wang1,2, H Geng4, X-D Chen1,2, Y Sun3, C-K Yeh1,2.   

Abstract

OBJECTIVE: Candida-induced denture stomatitis is a common debilitating problem among denture wearers. Previously, we described the fabrication of a new denture material that released antifungal drugs when immersed in phosphate buffered saline. Here, we use more clinically relevant immersion conditions (human saliva; 37°C) and measure miconazole release and bioactivity.
MATERIALS AND METHODS: Disks were prepared by grafting PNVP [poly(N-vinyl-2-pyrrolidinone)] onto PMMA [poly(methylmethacrylate)] using plasma initiation (PMMA-g-PNVP) and then loaded with miconazole. Drug-loaded disks were immersed in 10-100% human saliva (1-30 days). Miconazole release was measured and then tested for bioactivity vs miconazole-sensitive and miconazole-resistant Candida isolates.
RESULTS: HPLC was used to quantify miconazole levels in saliva. Miconazole-loaded disks released antifungal drug for up to 30 days. Higher drug release was found with higher concentrations of saliva, and, interestingly, miconazole solubility was increased with higher saliva concentrations. The released miconazole retained its anticandidal activity. After immersion, the residual miconazole could be quenched and the disks recharged. Freshly recharged disks displayed the same release kinetics and bioactivity as the original disks. Quenched disks could also be charged with chlorhexidine that displayed anticandidal activity.
CONCLUSIONS: These results suggest that PMMA-g-PNVP is a promising new denture material for long-term management of denture stomatitis.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Candida-associated denture stomatitis; antifungal treatment; drug delivery; rechargeable biomaterial

Mesh:

Substances:

Year:  2016        PMID: 26855200      PMCID: PMC4900923          DOI: 10.1111/odi.12456

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  33 in total

1.  Composition of in vitro denture plaque biofilms and susceptibility to antifungals.

Authors:  Hanadi Lamfon; Zubaida Al-Karaawi; Michael McCullough; Stephen R Porter; Jonathan Pratten
Journal:  FEMS Microbiol Lett       Date:  2005-01-15       Impact factor: 2.742

2.  Will there be a need for complete dentures in the United States in 2020?

Authors:  Chester W Douglass; Annie Shih; Larry Ostry
Journal:  J Prosthet Dent       Date:  2002-01       Impact factor: 3.426

Review 3.  Colonization of Candida species in denture wearers with emphasis on HIV infection: a literature review.

Authors:  Leticia F Perezous; Catherine M Flaitz; Millicent E Goldschmidt; Robert L Engelmeier
Journal:  J Prosthet Dent       Date:  2005-03       Impact factor: 3.426

4.  Candida-associated denture stomatitis in patients after immunosuppression therapy.

Authors:  M Golecka; U Ołdakowska-Jedynak; E Mierzwińska-Nastalska; E Adamczyk-Sosińska
Journal:  Transplant Proc       Date:  2006 Jan-Feb       Impact factor: 1.066

5.  Use of a new assay technique for quantification of antifungal activity of nystatin incorporated in denture liners.

Authors:  M R Truhlar; K Shay; P Sohnle
Journal:  J Prosthet Dent       Date:  1994-05       Impact factor: 3.426

6.  Determination of miconazole in human saliva using high-performance liquid chromatography.

Authors:  A Turner; D W Warnock
Journal:  J Chromatogr       Date:  1982-01-08

7.  Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance.

Authors:  J Chandra; D M Kuhn; P K Mukherjee; L L Hoyer; T McCormick; M A Ghannoum
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

8.  Systemic candidiasis in cancer patients.

Authors:  A W Maksymiuk; S Thongprasert; R Hopfer; M Luna; V Fainstein; G P Bodey
Journal:  Am J Med       Date:  1984-10-30       Impact factor: 4.965

Review 9.  Denture plaque--past and recent concerns.

Authors:  H Nikawa; T Hamada; T Yamamoto
Journal:  J Dent       Date:  1998-05       Impact factor: 4.379

10.  The effectiveness, in vitro, of miconazole and ketoconazole combined with tissue conditioners in inhibiting the growth of Candida albicans.

Authors:  D M Quinn
Journal:  J Oral Rehabil       Date:  1985-03       Impact factor: 3.837

View more
  1 in total

1.  Synthesis, Antifungal Activity, and Biocompatibility of Novel 1,4-Diazabicyclo[2.2.2]Octane (DABCO) Compounds and DABCO-Containing Denture Base Resins.

Authors:  Jenny L Herman; Yapin Wang; Elizabeth A Lilly; Thomas E Lallier; Brian M Peters; Suleiman Hamdan; Xiaoming Xu; Paul L Fidel; Mairi C Noverr
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.